Country: Switzerland

Roche, operating through its Diagnostics division under F. Hoffmann-La Roche Ltd, is a Switzerland-headquartered global healthcare company that focuses on the research, development, manufacturing, and distribution of in vitro diagnostics solutions and medical laboratory technologies. Standing as one of the world's largest and most recognized names in the diagnostics industry, Roche Diagnostics has steadily built a leading position across every major segment of laboratory testing, offering an exceptionally broad product portfolio developed to serve blood screening, core lab, molecular lab, pathology lab, point of care, digital solutions, and sequencing workflows. Its lineup spans clinical chemistry and immunoassay platforms, coagulation systems, mass spectrometry, urinalysis, nucleic acid testing (NAT), serology, syndromic testing, automated slide staining systems, IHC and ISH assays, companion diagnostics, digital pathology, blood gas and electrolyte analyzers, hospital glucose systems, molecular point-of-care instruments, next-generation sequencing (NGS) platforms and assays, along with globally trusted brands including cobas®, CoaguCheck®, VENTANA®, LightCycler®, MagNA Pure, KAPA, Harmony®, TIB Molbiol®, CustomBiotech, and the navify® digital health platform. Signature products such as the VENTANA® HE 600 histology staining system illustrate the company's approach, fully automating the drying, deparaffinization, staining, and coverslipping of FFPE microscope slides with throughput of up to 200 slides per hour and over 400 customizable protocols.

Backed by decades of pharmaceutical and diagnostic research expertise and modern manufacturing facilities worldwide, Roche combines refined engineering with rigorous quality assurance to deliver equipment that meets the highest healthcare standards. Its products are backed by widely respected certifications such as IVD CE marking according to European Union Directive 98/79/EC, along with EN 61010-1, IEC 61010-2-010, IEC 61010-2-081, EN 61326-1, and EN ISO 18113-1 compliance, reflecting the company's dedication to safety, precision, and consistent clinical performance. Roche also continues to advance patient care through its extensive focus on health topics that include cardiometabolic diseases such as heart failure and coronary artery disease, infectious diseases including antimicrobial resistance, sepsis, viral hepatitis, respiratory infections and sexual health, neurology and Alzheimer's disease, oncology spanning blood, breast, cervical, liver and lung cancer, and women's health covering gynecology, pregnancy care, and reproductive health.

Serving hospitals, clinical laboratories, pathology labs, research institutions, blood banks, and healthcare providers worldwide, Roche Diagnostics emphasizes innovation, sustainability, and long-term partnerships with the healthcare community. The company backs its systems with comprehensive services including Roche Healthcare Consulting, its navify® digital portal for laboratory connectivity and workflow integration, CareGiver remote support, and extensive customer training programs. Guided by its commitment to doing now what patients need next, Roche positions itself as a trusted Swiss partner for laboratory professionals, clinicians, and healthcare institutions seeking advanced, integrated, and clinically dependable diagnostic solutions on a truly worldwide scale.